Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. (2016)

First Author: Verhoef TI
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/tpj.2016.41

PubMed Identifier: 27272045

Publication URI: http://europepmc.org/abstract/MED/27272045

Type: Journal Article/Review

Volume: 16

Parent Publication: The pharmacogenomics journal

Issue: 5

ISSN: 1470-269X